Introduction {#s1}
============

In recent years, the reported incidence of dengue has risen rapidly. In the Asia-Pacific region, which bears 75% of the global dengue disease burden, there are more than 1.8 billion people at risk of infection with dengue viruses (DENV) ([@bib69]). Increased air travel and urbanisation could have contributed to the geographic spread of infection ([@bib25]; [@bib58]), with transmission by mosquitoes of the *Aedes* genus, including *Aedes aegypti* and *Aedes albopictus* ([@bib27]). DENV has four serotypes circulating, with infection conferring lifelong protection against the infecting serotype and short-lived protection against the others ([@bib53]; [@bib26]). Although four serotypes of DENV may co-circulate in South East Asia, only one serotype circulates in most of the South Pacific islands at any point in time ([@bib12]; [@bib34]).

Between November 2013 and July 2014, a major outbreak caused by DENV-3 occurred in Fiji, with more than 25,000 suspected cases reported ([Figure 1A](#fig1){ref-type="fig"}). Prior to the 2013/14 outbreak, there were eleven outbreaks of dengue recorded in Fiji, involving serotypes 1, 2 and 4 ([Table 1](#table1){ref-type="table"}). Most cases in 2013/14 occurred on Viti Levu, the largest and most populous island. This is administratively divided into the Central Division, which includes the port-capital Suva, and Western Division, which contains the urban centres of Lautoka and Nadi, where Fiji's major international airport is located. Dengue transmission in Central and Western Divisions is likely to be driven mostly by the *Aedes aegypti* vector, with *Aedes albopictus* most abundant in the Northern Division. *Aedes polynesiensis* and *Aedes pseudoscutellaris* are also present in all divisions ([@bib36]; [@bib46]). In response to the 2013/14 outbreak, considerable resources were dedicated to implementing control measures, including a nationwide vector clean-up campaign between 8th and 22nd March 2014 ([@bib8]). As well as media coverage and distribution of flyers to raise awareness about dengue prevention and protection, a major operation was put in place to remove rubbish that could act as egg laying habitats for mosquitoes. In total, forty-five tonnes of tyres and twenty-five tonnes of other containers were removed during this period.

![Geographical distribution of weekly lab tested suspected dengue cases in Northern (green), Western (blue) and Central (yellow) divisions between 27th October 2013 and 1 st July 2014.\
Points on the maps show locations of cases arranged by health centre they reported to; these are plotted with jitter and transparency to show concentrations of cases. (**A**) Weekly reported case totals for Northern, Western, Central and Eastern divisions. (**B**) Serosurvey study locations. Black circles show the 23 study clusters included in the analysis. (**C**) Age distribution of Central Division in the 2007 census (blue line) and ages of serosurvey participants in 2013 (black line).](elife-34848-fig1){#fig1}
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###### Reported dengue outbreaks in Fiji between 1930--2014.

Two studies ([@bib19]; [@bib37]) also included a post-outbreak serosurvey in Central Division. \*There is also evidence of DENV-3 circulation during this period ([@bib59]).

  Year      Main serotype   Reported cases   Seroprevalence   Source
  --------- --------------- ---------------- ---------------- ----------------------
  1930      ?               Thousands                         ([@bib36])
  1944-5    1               Thousands                         ([@bib49])
  1971-3    2               3413             26% (Suva)       ([@bib37])
  1974-5    1               16,203                            ([@bib49])
  1980      4               127                               ([@bib19])
  1981      1               18                                ([@bib31])
  1982      2               676                               ([@bib31])
  1984-6    ?               490                               ([@bib19])
  1988      ?               22                                ([@bib19])
  1989-90   1\*             3686             54% (Suva)       ([@bib19]; [@bib64])
  1997-8    2               24,780                            ([@bib68])
  2001-3    1               ?                                 ([@bib28])
  2008      4               1306                              ([@bib43]; [@bib47])
  2013-14   3               25,496                            Fiji MOH

Large dengue outbreaks can place a substantial public health burden on island populations ([@bib19]; [@bib56]). However, understanding the dynamics of infection and evaluating the impact of vector control measures remains challenging. There is a limited evidence base for control measures even in controlled trials ([@bib7]; [@bib29]), and post-outbreak evaluation is hindered by the fact that the size and duration of major outbreaks can be influenced by several factors, including population immunity, human movement, seasonal variation in transmission, and proportion of people living in urban, peri-urban and rural communities. In Fiji, dengue outbreaks typically occur during the wetter, warmer season between December and July, when vectors are most abundant ([@bib24]). Although surveillance data can provide broad insights into arbovirus transmission patterns ([@bib16]; [@bib23]; [@bib63]), and cross-sectional serosurveys can be used to measure contemporary levels of immunity ([@bib4]; [@bib20]; [@bib37]; [@bib64]), characterising infection dynamics in detail requires cohort-based seroepidemiological studies ([@bib16]; [@bib50]), which can be difficult to implement in island settings where outbreaks are infrequent and difficult to predict.

Immediately before the 2013/14 dengue outbreak in Fiji, a population-representative serological survey had been conducted to study leptospirosis and typhoid ([@bib33]). To investigate patterns of dengue infection in 2013/14, we followed up participants from this survey in Central Division, to obtain a set of paired pre- and post-outbreak serological samples (see Materials and methods). We tested the paired samples for anti-DENV IgG antibodies using ELISA and a recombinant antigen-based microsphere immunoassay (MIA), and combined these data with dengue surveillance data to compare possible explanations for the outbreak dynamics. We measured age-specific and spatial patterns of infection and reported disease, and tested whether there were demographic and environmental risk factors associated with infection. Having characterised factors shaping individual-level infection risk, we used a Bayesian approach to fit a transmission dynamic model to both the serological survey and surveillance data in order to estimate the contribution of climate and control measures to the decline in transmission observed in 2014.

Results {#s2}
=======

The pre- and post-outbreak serological survey included 263 participants from the Central Division, with age distribution of these participants consistent with the population distribution ([Figure 1B--C](#fig1){ref-type="fig"}). We found that 58.6% of participants (154/263) were ELISA seropositive to at least one DENV serotype in late 2013. Two years later, in October/November 2015, this had risen to 74.5% (196/263). Additional serotype-specific MIA tests confirmed that the largest rise in seroprevalence in Central Division was against DENV-3, from 33.1% to 53.2% ([Table 2](#table2){ref-type="table"}), consistent with the majority of RT-PCR-confirmed samples during the outbreak being of this serotype.
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###### Number of participants who were seropositive to DENV in 2013 and 2015 as measured by ELISA and MIA.

MIA any DENV denotes participants who were MIA seropositive to at least one DENV serotype. 95% CI shown in parentheses.

  Test           N     2013   2013 (%)              2015   2015 (%)              Difference
  -------------- ----- ------ --------------------- ------ --------------------- ---------------------
  ELISA          263   154    58.6% (52.3--64.6%)   196    74.5% (68.8--79.7%)   16% (11.8--21%)
  MIA any DENV   263   193    73.4% (67.6--78.6%)   216    82.1% (77--86.6%)     8.75% (5.62--12.8%)
  MIA DENV-1     263   177    67.3% (61.3--72.9%)   198    75.3% (69.6--80.4%)   7.98% (5.01--11.9%)
  MIA DENV-2     263   33     12.5% (8.8--17.2%)    41     15.6% (11.4--20.5%)   3.04% (1.32--5.91%)
  MIA DENV-3     263   87     33.1% (27.4--39.1%)   140    53.2% (47--59.4%)     20.2% (15.5--25.5%)
  MIA DENV-4     263   79     30.0% (24.6--36%)     99     37.6% (31.8--43.8%)   7.6% (4.71--11.5%)

To characterise patterns of infection between 2013 and 2015, we first considered individual-level demographic, behavioural and environmental factors. Using a univariable logistic regression model, we compared seroconversion determined by ELISA with questionnaire responses about household environment and health-seeking behaviour ([Table 3](#table3){ref-type="table"}). The factors most strongly associated with seroconversion between 2013--15 among initially seronegative participants were: living in an urban or peri-urban environment (odds ratio 2.18 \[95% CI: 0.953--5.11\], p=0.068); reporting fever in preceding two years (odds 2.94 \[1.08--8.38\], p=0.037); and visiting a doctor with fever in the preceding two years (odds 3.15 \[1.06--10.10\], p=0.043). Of the participants who seroconverted, 10/38 (26.3% \[13.4--43.1%\]) reported visiting a doctor with fever in the preceding two years, 2/38 (5.26% \[0.644--17.7%\]) reported fever but did not visit a doctor, and 26/38 (68.4% \[51.3--82.5%\]) did not report fever ([Supplementary file 1A](#supp1){ref-type="supplementary-material"}).
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###### Risk factors from a univariable logistic regression model.

Sample population was all individuals who were seronegative in 2013 (n = 97), and outcome was defined as seroconversion as measured by ELISA. Number indicates total individuals with a given characteristic.

  Variable                                                          Number   Odds ratio           p value
  ----------------------------------------------------------------- -------- -------------------- ---------
  Demographic characteristics                                                                     
  Age under 20                                                      61       0.49 (0.21--1.13)    0.10
  Male                                                              49       0.81 (0.36--1.84)    0.62
  iTaukei ethnicity                                                 85       1.33 (0.39--5.32)    0.66
  Environmental factors present                                                                   
  Mosquitoes                                                        90       4.19 (0.68--80.85)   0.19
  Used car tires                                                    61       1.80 (0.77--4.42)    0.18
  Open water container(s)                                           61       1.49 (0.64--3.58)    0.37
  Air conditioning                                                  23       0.46 (0.15--1.26)    0.15
  Blocked drains                                                    53       1.04 (0.46--2.38)    0.92
  Location                                                                                        
  Urban or peri-urban                                               50       2.18 (0.95--5.11)    0.07
  Health seeking behaviour                                                                        
  Fever in preceding 2 years                                        20       2.94 (1.08--8.38)    0.04
  Visited doctor with fever in preceding 2 years                    16       3.15 (1.06--10.13)   0.04
  Household member visited doctor with fever in preceding 2 years   9        2.08 (0.52--8.94)    0.30

As well as estimating infection by measuring seroconversion based on threshold values, we also considered the distribution of ELISA values. There was a noticeable right shift in this distribution between 2013 and 2015, with ELISA values increasing across a range of values ([Figure 2A](#fig2){ref-type="fig"}). As some of the individual-level changes in value between the two tests were likely to be due to measurement error ([@bib55]), we fitted a mixture model to the distribution of changes in ELISA value ([Figure 2B](#fig2){ref-type="fig"}). We used a normal distribution with mean zero to capture measurement error, and a gamma distribution to fit rise that could not be explained by this error function. The fitted model suggested that a rise in value of at least three was more likely to be a genuine increase rather than measurement error, as shown by the dashed line in [Figure 2B](#fig2){ref-type="fig"}.

![Distribution of ELISA values for anti-DENV IgG over time.\
(**A**) Distribution of values in 2013 and 2015. Orange bars show observed proportion of samples with each value in 2013; blue bars show proportions in 2015. Dashed lines show threshold for seronegativity and seropositivity. (**B**) Change in ELISA values between 2013 and 2015. Bars show distribution of values. Grey line shows estimated uncertainty in assay measurements; blue line shows estimated increase in value following the 2013--14 epidemic; thin black line shows overall fitted distribution (model $R^{2}$=0.93). Dashed line shows probability of infection for a given rise in value. (**C**) Relationship between value in 2013 and rise between 2013 and 2015, adjusting for probability of infection as shown in [Figure 2B](#fig2){ref-type="fig"}. Points show 1000 bootstrap samples of the data with replacement, with opacity of each point proportional to probability of infection. Blue line shows prediction from generalized additive model, with data points weighted by probability of infection; shaded region shows 95% CI (model $R^{2}$=0.31).](elife-34848-fig2){#fig2}

To explore the relationship between the initial ELISA value and rise post-outbreak, given that an individual had been infected, we fitted a generalized additive model to the data and weighted each observation by the probability that a specific participant had been infected based on the dashed line in [Figure 2B](#fig2){ref-type="fig"}. By adjusting to focus on likely infections, we found a negative relationship between initial value and subsequent rise, with ELISA values near zero rising by around 10 units, but higher values exhibiting a smaller rise ([Figure 2C](#fig2){ref-type="fig"}). Using this approach, we also found strong evidence that self-reported symptoms were associated with larger rise in ELISA value, given likely infection. Using a logistic model with self-reported symptoms as outcome and change in value as dependent variable, adjusting for initial value and again weighting by probability of infection, we found that individuals who reported a fever in the preceding two years had a predicted rise in ELISA value that was 2.2 (95% 0.77--3.6) units higher than those who did not (p=0.003). Further, individuals who reported visiting a doctor with fever had a predicted value 3.3 (1.8--4.9) higher than others (p=0.0005).

Examining age patterns of seroprevalence, we found an increase in the proportion seropositive against DENV with age in both 2013 and 2015, and a rise in seroprevalence was observed in almost all age groups after the 2013/14 outbreak ([Figure 3A](#fig3){ref-type="fig"}). However, the high levels of seroprevalence in older age groups made it challenging to estimate age-specific probability of infection, because there was a relative lack of serologically naive individuals in these groups to act as a denominator ([Table 4](#table4){ref-type="table"}). We therefore again used rise in ELISA value as a correlate of infection, based on [Figure 2B](#fig2){ref-type="fig"}. As well as producing more precise estimates of infection risk in older groups ([Table 4](#table4){ref-type="table"}), this approach also suggested that individuals aged 10--19 years were most likely to be infected. This is in contrast to the surveillance data, which indicated the highest per capita level of reported disease was in the 20--29 age group ([Figure 3B](#fig3){ref-type="fig"}).

![Age patterns of immunity and infection during 2013--15.\
(**A**) Proportion of each age group seropositive against DENV as measured by ELISA (blue squares) and DENV-3 by MIA (green circles). Lighter points show 2013 results, darker points show 2015; lines show 95% binomial confidence intervals. (**B**) Comparison of estimated age-specific infection and reported cases. Black points, estimated proportion infected based on ELISA rise indicated in [Figure 2B](#fig2){ref-type="fig"}; red points, cases reported per 1000 people in each age group; lines show 95% binomial confidence intervals.](elife-34848-fig3){#fig3}
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###### Estimated age-specific attack rates based on raw ELISA values, and seroconversion using ELISA cutoff.

Estimated proportions of infections were calculated from the total of the probabilities that each individual in that age group had been infected, based on change in ELISA values between 2013 and 2015 ([Figure 2B](#fig2){ref-type="fig"}). Binomial 95% confidence intervals are shown in parentheses.

  Age      N     Propn infected based on ELISA values   Seronegative   Seroconverted   Seroconverted (%)
  -------- ----- -------------------------------------- -------------- --------------- ---------------------
  0--9     27    39.3% (22.2--59.3%)                    21             6               28.6% (11.3--52.2%)
  10--19   59    56% (44.1--67.8%)                      40             14              35% (20.6--51.7%)
  20--29   45    44.7% (31.1--60%)                      14             8               57.1% (28.9--82.3%)
  30--39   41    38% (24.4--53.7%)                      12             4               33.3% (9.92--65.1%)
  40--49   28    24.2% (10.7--39.3%)                    3              3               100% (29.2--100%)
  50--59   28    25.1% (10.7--42.9%)                    5              2               40% (5.27--85.3%)
  60--69   21    27.8% (9.52--47.6%)                    1              1               100% (2.5--100%)
  70+      14    36.6% (14.3--64.3%)                    1              0               0% (0--97.5%)
  Total    263   39.6% (33.8--45.6%)                    97             38              39.2% (29.4--49.6%)

Next, we explored spatial patterns of infection in different communities. Previous studies have suggested that dengue outbreaks can spread outwards from urban hubs to more rural areas ([@bib15]; [@bib54]). A similar spatial pattern was observed from the surveillance data during the early stages of the 2013/14 Fiji outbreak ([Figure 4A](#fig4){ref-type="fig"}). The first case was reported at Colonial War Memorial Hospital (CWM), Fiji's largest hospital located in central urban Suva, in the week ending 4th November 2013. The outbreak took 9 weeks to reach the furthest reporting point from CWM in Central Division, a health centre 51 km away by Euclidean distance (i.e. as the crow flies). We found limited association between Euclidean distance from CWM and proportion of study cluster seropositive to DENV-3 in 2015 ([Figure 4B](#fig4){ref-type="fig"}): the Pearson correlation between ELISA seropositivity in each cluster and distance from CWM was $\rho$= --0.12 (p=0.59); for DENV-3 the correlation coefficient was $\rho$= --0.46 (p=0.03). However, we found no significant association between the Euclidean distance from CWM and proportion of cluster infected ([Figure 4C](#fig4){ref-type="fig"}). Pearson correlation between estimated proportion infected based on change ELISA value in each cluster and distance from CWM was $\rho$= 0.22 (p=0.30); for DENV-3 the correlation was $\rho$= --0.36 (p=0.09). We did find evidence of dengue seroconversion in every cluster, however, suggesting that the outbreak eventually spread throughout Central Division.

![Spatial pattern of infection and immunity in Central Division.\
(**A**) Relationship between dengue cases reported by each health centre at the start of the outbreak and Euclidean distance from Colonial War Memorial Hospital (CWM) in Suva. Area of circle is proportional to number of cases reported in that week; each health centre is represented by a different colour. (**B**) Proportion seropositive in each serosurvey study cluster in 2015 vs Euclidean distance from CWM. Blue, ELISA data; green, MIA data; circles, urban or peri-urban clusters; crosses, rural clusters. (**C**) Proportion infected in each serosurvey study cluster vs Euclidean distance from CWM. Blue, estimate based on ELISA data, using adjustment in [Figure 2B](#fig2){ref-type="fig"}; green, seroconversion based on MIA for individuals who were initially seronegative; circles, urban or peri-urban clusters; crosses, rural clusters.](elife-34848-fig4){#fig4}

As we did not find strong evidence of individual or community-level heterogeneity in infection, we incorporated the surveillance data and paired serological survey data into mathematical models to test explanations for the observed outbreak dynamics at the division level. We considered three model variants: a simple age-structured model of vector-borne transmission dynamics; the same model structure, but with climate-driven variation in transmission; and a model with both climate-driven variation in transmission and a potential additional reduction in transmission coinciding with the clean-up campaign in March 2014. When we jointly fitted the models to surveillance data and age-specific immunity, as measured by seropositivity to DENV-3 by MIA in 2013 and 2015, the model with both climate-driven variation in transmission and an additional transmission reduction performed best as measured by AIC and DIC ([Figure 5A--B](#fig5){ref-type="fig"} and [Table 5](#table5){ref-type="table"}). This additional reduction in transmission was modelled using a flexible additional sigmoidal transmission rate, and was constrained so that the midpoint of the decline occurred after the start of the campaign on 8th March 2014 ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}); we estimated a reduction of 57% (95% CrI: 42--82%) in transmission that coincided with the clean-up campaign ([Figure 5C](#fig5){ref-type="fig"}). As the effective reproduction number was near the critical value of one when the clean-up campaign was introduced ([Figure 5D--E](#fig5){ref-type="fig"}), it suggests that the main contribution of control measures may have been to bring DENV-3 infections to sufficiently low levels for transmission to cease earlier. We obtained the same conclusions when ELISA rather than MIA seroprevalence was used to quantify immunity during model fitting ([Table 5](#table5){ref-type="table"} and [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). It was noticeable that the model fitted to the ELISA data produced a qualitatively better fit to the surveillance data than the model fitted to MIA data. This was because the observed MIA values imposed a stronger constraint on the plausible range of model estimated seroprevalence ([Figure 5B](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2B](#fig5s2){ref-type="fig"}), so in comparison the model fitted to ELISA data was able to attribute more of the slowdown in growth in the surveillance data during January/February to the accumulation of herd immunity.

![Impact of climate and control measures on DENV transmission during 2013/14, using a model jointly fitted to surveillance and serological data from Central Division.\
(**A**) Model fit to surveillance data. Solid black dots, lab tested dengue cases; black circles, DLI cases; black line, total cases. Blue line shows median estimate from fitted model; dark blue region, 50% credible interval; light blue region, 95% CrI; red region shows timing of clean-up campaign. (**B**) Pre- and post-outbreak DENV immunity. Red dots show observed MIA seroprevalence against DENV-3 in autumn 2013 and autumn 2015; hollow dots, under 20 age group; solid dots, 20+ age group; lines show 95% binomial confidence interval. Dashed orange line shows model estimated rise in immunity during 2013/14 in under 20 group; solid line shows rise in 20+ group; shaded region shows 95% CrI. (**C**) Estimated variation in transmission over time. Red region, timing of clean-up campaign; green line, relative transmission as a result of control measures. Black line, basic reproduction number, $R_{0}$; blue line, effective reproduction number, $R$, accounting for herd immunity and control measures. Shaded regions show 95% CrIs. Dashed line shows the $R = 1$ herd immunity threshold. (**D**) Average monthly rainfall (blue lines) and daily temperature (orange line, with black line showing weekly moving average) in Fiji during 2013--15. (**E**) Change in $R_{0}$ over time. Shaded regions show 95% CrIs.](elife-34848-fig5){#fig5}
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###### Comparison of model performance using AIC and DIC.

  Model                      Serological data   AIC     $\Delta$AIC   DIC     $\Delta$DIC
  -------------------------- ------------------ ------- ------------- ------- -------------
  SEIR                       MIA                716.9   66.69         625.6   35.62
  SEIR + climate             MIA                672.9   22.7          616.6   26.65
  SEIR + climate + control   MIA                650.2   0             589.9   0
  SEIR                       ELISA              675.1   25.74         1219    643.2
  SEIR + climate             ELISA              668.4   19.09         599.3   23.52
  SEIR + climate + control   ELISA              649.3   0             575.8   0

Fitting to the DENV-3 MIA seroprevalence data, we estimated that the mean basic reproduction number, $R_{0}$, over the course of the year was 1.12 (95% CrI: 1.02--1.25), with a peak value of 1.87 (1.70--2.07) in January 2014 ([Table 6](#table6){ref-type="table"}). Posterior estimates are shown in [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"} and correlation plots for the transmission rate parameters are shown in [Figure 5---figure supplement 4](#fig5s4){ref-type="fig"}. Accounting for stochastic variability in weekly case reporting, we estimated that 11% (1.1--39%) of infections were reported as laboratory-tested cases and 9.3% (1.1--39%) were reported as DLI cases. The estimated value of $R_{0}$ was larger for the model fitted to ELISA data, with a mean of 1.49 (1.35--1.69); this was the result of a larger proportion of the population assumed to be initially immune to infection.
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###### Parameter estimates for the 2013/14 dengue epidemic when the model was fitted to MIA or ELISA data.

Median estimates are shown, with 95% credible intervals shown in parentheses. Mean $R_{0}$ is the average basic reproduction number over a year. Proportion reported was calculated by sampling from the negative binomial distribution that defines the model observation process (i.e. the credible interval reflects both underreporting and dispersion in weekly case reporting). $I_{hc}^{0}$ and $I_{ha}^{0}$ denote the number of initially infectious individuals in the younger and older age group respectively.

  Parameter                      MIA                 ELISA
  ------------------------------ ------------------- -------------------
  Mean $R_{0}$                   1.12 (1.02--1.25)   1.49 (1.35--1.69)
  Peak $R_{0}$                   1.87 (1.7--2.07)    2.5 (2.29--2.81)
  Control reduction              0.57 (0.42--0.82)   0.70 (0.37--0.95)
  Proportion reported, lab (%)   11 (1.1--39)        13 (2.6--36)
  Proportion reported, DLI (%)   9.3 (0.99--37)      12 (2.8--35)
  $I_{hc}^{0}$                   140 (18--550)       0.98 (0.21--3.8)
  $I_{ha}^{0}$                   130 (19--680)       1.3 (0.0094--57)

As well as performing worse under AIC and DIC, the model with only climate-driven variation in transmission could not capture the overall shape of the surveillance data ([Figure 5---figure supplement 5](#fig5s5){ref-type="fig"}). The basic model, which had neither climate-driven variation in transmission nor an additional reduction in transmission, could not jointly reproduce both sets of data either ([Figure 5---figure supplement 6](#fig5s6){ref-type="fig"}). Fitting the basic model to the surveillance data alone, we could reproduce the observed incidence pattern under the assumption of a simple immunising epidemic. Specifically, the reported cases were consistent with an epidemic that declined as a result of depletion of the susceptible population ([Figure 5---figure supplement 7](#fig5s7){ref-type="fig"}). However, this basic epidemic model underestimated the initial level of immunity and overestimated final immunity. A similar discrepancy between serological surveys and surveillance data has been noted in previous arbovirus modelling studies, albeit for ZIKV rather than DENV ([@bib23]; [@bib32]; [@bib13]).

Discussion {#s3}
==========

We analysed surveillance reports and serological survey data to examine the dynamics of a major 2013/14 dengue outbreak in Fiji. Owing to the sporadic and unpredictable nature of dengue outbreaks in the Pacific ([@bib12]), it is rare to have access to paired population-representative sera collected before and after such an epidemic. Comparing surveillance and serological survey data made it possible to investigate the relationship between observed reported cases and the true attack rate and quantify the relative role of climate, herd immunity and control measures in shaping transmission.

Analysis of detailed serological data provided insights into age-specific patterns of infection that would not be identified from seropositivity thresholds alone. We estimated the highest infection rate was in the 10--19-year-old age group, whereas proportionally the most reported cases were in the 20--29-year-old group. The apparent disparity between reported cases and infections estimated from the serological survey may be the result of secondary DENV infections causing more severe clinical disease and therefore increasing the likelihood of seeking medical care ([@bib42]). The ELISA results suggested that fewer than 50% of individuals under age 20 had experienced DENV infection in 2013 ([Figure 3A](#fig3){ref-type="fig"}), which means an infection during the 2013/14 outbreak in this group was more likely to be primary than secondary. In contrast, the majority of 20--29 year olds already had evidence of infection in 2013, and hence 2013/14 outbreak would have generated relatively more secondary or tertiary infections in this group. In addition, if age-specific infection rates are indeed higher in younger groups, it means that estimating population attack rates based on the proportion of seronegative individuals infected may over-estimate the true extent of infection. Focusing on the seronegative subset of the population leads to children being over-sampled, which in our data inflates attack rate estimates by around 10% compared to estimates based on change in ELISA value ([Table 4](#table4){ref-type="table"}).

We also found little evidence of spatial heterogeneity in seroconversion. Although the locations of health centres reporting cases in the early stages of the outbreak suggested infection spread outwards from central Suva, we found evidence of DENV infection in all study clusters. This suggests that spatial structure may be more important in driving transmission dynamics early in the outbreak, but might not influence the final attack rate. One limitation of this comparison is that we did not have information on outbreak dynamics in the community: in the surveillance data, we only had the location of the health centres that cases reported to, rather than the location where infection likely occurred.

Analysis of risk factors suggested that presence of self-reported symptoms between 2013--15 was associated with DENV infection. There was also a strong association between rise in ELISA value and self-reported symptoms in individuals who were likely infected, which suggests that raw values from serological tests could potentially be used to estimate the proportion of a population who were asymptomatic during a dengue outbreak, even in older age groups that were already seropositive. However, it is worth noting that the questionnaire that accompanied the serosurvey was brief and only asked about fever and visits to a doctor with fever; there may be specific factors that can better predict prior infection in such settings. We also conducted the follow up survey around 18 months after the outbreak, which means recall bias is a potential limitation of the risk factor analysis. We did not identify environmental factors that were significantly associated with infection, likely as a result of the relatively small sample size in the serological survey, but the estimated odds ratios were broadly consistent with factors that would be expected to increase or decrease infection risk ([Table 3](#table3){ref-type="table"}).

To investigate potential explanations for the outbreak decline in early 2014, we fitted a transmission dynamic model with two human age groups to both surveillance and serological survey data. Our analysis shows the benefits of combining multiple data sources: with surveillance data alone, it would not have been possible to distinguish between self-limiting outbreak driven by a decline in the susceptible population, and one that had ceased for another reason. With the addition of serological data in the model fitting, however, our model was able to quantify the relative contribution of herd immunity, climate and control measures to the outbreak dynamics. In particular, this model suggested that seasonal variation in transmission and herd immunity alone could not explain the fall in transmission. However, an additional decline in transmission in March 2014, which coincided with a nationwide vector clean-up campaign, could better capture the observed patterns in serological and surveillance data.

There are some limitations to our modelling analysis. First, we assumed that seropositivity in IgG antibody tests was equivalent to protective immunity. High levels of neutralising antibodies have been shown to correlate with protection from symptomatic infection ([@bib30]), but it remains unclear precisely how much an individual with a given ELISA or MIA value contributes to transmission. Second, we focused on seroprevalence against DENV-3 in the main modelling analysis. As prior infection with one dengue serotype can lead to a cross-reactive immune response against other serotypes ([@bib26]), we fitted the model to ELISA results (which were not serotype specific) as a sensitivity analysis; this produced the same overall conclusions about which model performed best. Third, we used a flexible time-dependent transmission rate to capture a potential reduction in transmission as a result of control measures in March 2014. The clean-up campaign included multiple concurrent interventions, which occurred alongside ongoing media coverage of the outbreak; it was therefore not possible to untangle how specific actions -- such as vector habitat removal or changes in community behaviour that reduced chances of being bitten -- contributed to the outbreak decline. Moreover, factors unrelated to control, such as spatial structure or local weather effects, may also have contributed to the observed decline in transmission; there was heavy rain and flooding in Viti Levu at the end of February 2014 ([@bib1]).

Although we used a simple function to capture the potential impact of rainfall on vector density, it is unlikely that a more detailed mechanistic relationship would improve the model fit. The peak in rainfall in 2013/14 coincided with the peak in dengue cases; for rainfall to have strongly influenced observed transmission via a reduction in larval carrying capacity, it would need to have peaked earlier, to account for the time delays involved in the vector life cycle ([@bib35]). We also assumed that all of the population could potentially be infected in the model. Some of the discrepancy between the high attack rate predicted by a randomly mixing model and lower observed seroconversion could in theory be explained by heterogeneity in transmission ([@bib23]), which would be expected to reduce the overall proportion infected during an outbreak. If such heterogeneity exists, it is unlikely to act in an 'all-or-nothing' manner over time, with the same individuals remaining at low risk: the high level of seroprevalence in older age groups suggests that only a small proportion of individuals have consistently avoided infection ([Figure 3](#fig3){ref-type="fig"}).

Finally, our analysis focused on Central Division, Fiji. However, much of the data used in our model -- such as surveillance data, post-outbreak serology, and climate information -- would be available for other settings. For factors that are harder to measure without paired serology, like age-specific infection rates and potential effectiveness of control measures, a joint inference approach could be employed that combines prior distributions based on the data presented here with available outbreak data from the other location of interest ([@bib23]).

Despite these caveats, our results show that transmission dynamic models developed using a combination of serological surveys and surveillance data can be valuable tool for examining dengue fever outbreaks. As well as providing insights into the transmission and control of dengue, the analysis has implications for forecasting of future epidemics. During February and March 2014, members of the research team based at London School of Hygiene and Tropical Medicine provided real-time analysis and outbreak projections for the Fiji National Centre for Communicable Disease Control, to support public health planning ([@bib41]). However, a lack of serological data at the time meant it was necessary to make strong assumptions about pre-existing population immunity. With up-to-date population representative serology now available, forecasting models during future outbreaks will be able to include a more realistic herd immunity profile from the outset. Such seroepidemiological approaches could also be employed in other settings, to provide improved forecasts of dengue transmission dynamics and potential disease burden prior to and during outbreaks, as well as quantitative retrospective evaluation of the effectiveness of control measures.

Materials and methods {#s4}
=====================

Surveillance data {#s4-1}
-----------------

In December 2013, the dengue outbreak in Fiji was determined to be due to DENV-3 by RT-PCR performed on serum samples sent to the World Health Organization Collaborating Centre for Arbovirus Reference and Research at the Queensland University of Technology (QUT, Brisbane). Hereafter, samples that were ELISA reactive for NS1 antigen or IgM were presumed to be to DENV-3 infections with a sub-sample of them sent for confirmatory serotyping at QUT, the Institut Louis Malardé (ILM) and the US Centers for Disease Control and Prevention. Of the 10,442 laboratory tested cases that were notified to the Fiji National Centre for Communicable Disease Control between 27th October 2013 and 4th March 2014, 4115 (39.4%) were reactive for DENV NS1 and/or anti-DENV IgM. After this time period, dengue surveillance was transitioned from laboratory to clinical-based reporting (i.e. dengue-like illness, DLI) due to the size of the outbreak ([Figure 6](#fig6){ref-type="fig"}).

![Geographical distribution of cases reported each week.\
(**A**) Lab -tested dengue cases reported in Northern (green), Western (blue) and Central (yellow) divisions between 27th October 2013 and 31st August 2014. (**B**) Total tested and confirmed cases in Central division (solid and dashed lines respectively), as well as proportion of cases that tested positive (grey line). (**C**) Dengue-like illness (DLI) over time. (**D**) Total suspected cases (i.e. tested and DLI).](elife-34848-fig6){#fig6}

Between 27th October 2013 and 31st August 2014, 25,494 suspected cases of dengue (i.e. laboratory tested or confirmed or DLI) were notified to the Fijian Ministry of Health. Of these, 12,413 (48.7%) cases were in Central Division, predominantly in the greater Suva area ([Figure 1](#fig1){ref-type="fig"}). 10,679 cases were reported in the Western Division, 2048 cases were reported in the Northern division, largely in or near Labasa, the largest town of Vanua Levu island, and 354 cases were reported in the Eastern Division. For the lab-confirmed cases, date of testing was used to compile weekly case incidence time series; for the DLI data, date of presentation to a health centre was used, as these dates were most complete. Filter paper-based surveillance conducted by ILM between December 2013 and October 2014 found 24 samples positive for DENV-3 by RT-PCR, as well as three samples positive for DENV-2 and one for DENV-1. During 2014/15, there was a flare up of DENV-2 in Fiji. However, relatively few cases occurred on Viti Levu: of the 543 confirmed cases nationally between 1st January 2015 and 29th April 2015, 437 cases (80%) were from the Northern Division ([@bib67]).

Serological survey {#s4-2}
------------------

We conducted a serological survey using pre- and post-outbreak sera from 23 communities in Central Division. Pre-outbreak sera were collected as part of population representative community-based surveys of leptospirosis and typhoid conducted in Central Division between September and November 2013 ([@bib33]; [@bib65]). Population-proportionate sampling was used to select local nursing zones (the smallest administrative unit). From each of these zones, one community was randomly selected, followed by 25 households from each community and one individual from each of the households. Coincidentally, the sample collection in Central Division finished the same week as the first dengue cases were reported ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Post-outbreak sera were collected during a follow-up study carried out in October and November 2015. Field teams visited participants in Central Division who had previously participated in the 2013 serological study and had consented to being contacted again for health research.

Participants who gave informed consent for the 2015 study completed a questionnaire and provided a 5 ml blood sample. The study was powered to measure the rise in prevalence of anti-DENV antibodies between 2013--15. Historical dengue outbreaks in Fiji ([Table 1](#table1){ref-type="table"}) suggested we would expect to see seroconversion in at least 20% of the study population. Allowing for 5% seroreversion, and 0.05 probability of type-1 error, McNemar's test suggested 250 paired samples could detect a 15% increase in seroprevalence with 95% power, and a 20% increase with $\approx$100% power. We also collected data on potential risk factors and healthcare-seeking behaviour during this period. The questionnaire asked for details of fever and related visits to a doctor in the preceding two years, and the same for household members in the preceding two years. The questionnaire also recorded details of household environment, including potential mosquito breeding grounds ([Supplementary file 2](#supp2){ref-type="supplementary-material"}).

Ethical considerations {#s4-3}
----------------------

The 2013 typhoid and leptospirosis studies and the 2015 follow up study were approved by the Fiji National Research Ethics Review Committee (ref 2013--03 and 2015.111.C.D) and the London School of Hygiene and Tropical Medicine Observational Research Ethics Committee (ref 6344 and 10207). Participants in the 2015 follow up study were people who had previously given informed consent to have their blood tested as part of a public health serum bank established in the 2013 typhoid and leptospirosis serosurvey, and agreed to be contacted again by public health researchers. The study was explained in English or the local iTaukei language by bilingual field officers, at the potential participants' preference. Adults gave written informed consent, or thumbprinted informed consent witnessed by a literate adult independent from the study. For children age 12--17 years, written consent was obtained from both the parent and the child. For children aged under 12 years, written consent was obtained from the parent only, though information was provided to both.

Serological testing of paired sera {#s4-4}
----------------------------------

Paired pre- and post-outbreak serum samples were tested using an indirect IgG ELISA kit (PanBio Cat No 01PE30), according to manufacturer guidelines. This assay employs recombinant DENV envelope proteins of all four serotypes ([@bib39]). Samples with ELISA value of $\leq$9 PanBio units were defined as seronegative, $\geq$11 PanBio units seropositive, and values between 9 and 11 as equivocal. Seroconversion was defined as a change from seronegative to seropositive status. Because the indirect IgG ELISA does not distinguish between DENV serotypes, samples were also tested against each of the four specific DENV serotypes using a recombinant antigen-based microsphere immunoassay (MIA), as previously used to examine seroprevalence against different flaviviruses in French Polynesia ([@bib6], [@bib5]). Specifically, we wanted to measure the change in seropositivity to DENV-3 during the study period. As an additional validation, a subset of fifty samples from Central Division -- including a mixture of those seronegative and seropositive by ELISA and MIA -- were tested for the presence of neutralising antibodies against each of the four DENV serotypes using a neutralisation assay as previously described ([@bib11]). A neutralisation titre of $\geq$20 was defined as seropositive ([Figure 6---figure supplement 2A](#fig6s2){ref-type="fig"}). For both MIA and neutralisation assay results, the largest change in seropositivity was for DENV-3 ([Supplementary file 1B](#supp1){ref-type="supplementary-material"}). When seropositivity to any DENV (i.e. seropositive to at least one serotype) was compared, a similar change was observed across ELISA, MIA and neutralisation assay results between 2013 and 2015.

Serological modelling {#s4-5}
---------------------

Based on ELISA seropositivity in 2015 alone, it would not be possible to identify infections during the 2013/14 outbreak among individuals who were initially seropositive in 2013. We therefore examined the changes in paired individual-level ELISA values between 2013 and 2015. To estimate the probability that a given increase in ELISA value was the result of a genuine rise rather than measurement error, we fitted a two distribution mixture model to the distribution of changes in value between 2013 and 2015. We used a normal distribution with mean equal to zero to reflect measurement error, and a gamma distribution to capture a rise that could not be explained by the symmetric error function. The observed changes in ELISA value we fitted to ranged from −6 to 20; we omitted two outliers that had a change in value of −9 between 2013 and 2015, as these could not be explained with a normally distributed measurement error function. It was not possible to perform the same analysis using the MIA data because unlike the ELISA and neutralisation assay data, the raw MIA values did not follow a bimodal distribution that indicated likely naive and previously exposed individuals ([Figure 6---figure supplement 2B](#fig6s2){ref-type="fig"}). We used a generalized additive model with binomial link function to examine the relationship between ELISA value in 2013 and rise between 2013 and 2015, with data points weighted by probability that the change in ELISA value was the result of a genuine rise rather than measurement error. Risk factor analysis was performed using a univariable logistic regression model. Both were implemented using the mgcv package in R version 3.3.1 ([@bib66]; [@bib48]).

Transmission model {#s4-6}
------------------

### Model structure {#s4-6-1}

We modelled DENV transmission dynamics using an age-structured deterministic compartmental model for human and vector populations, with transitions between compartments following a susceptible-exposed-infective-removed (SEIR) structure ([@bib32]; [@bib38]; [@bib44]). As human population size was known, but the vector population was not, the human compartments were specified in terms of numbers and vectors in terms of proportions. Upon exposure to infection, initially susceptible humans ($S_{h}$) transitioned to a latent class ($E_{h}$), then an infectious class ($I_{h}$) and finally a recovered and immune class ($R_{h}$). The mosquito population was divided into three classes: susceptible ($S_{v}$), latent ($E_{v}$), and infectious ($I_{v}$). Mosquitoes were assumed to be infectious until they died. We had two human age groups in the model: aged under 20 (denoted with subscript $c$), and aged 20 and over (denoted with subscript $a$). We included births and deaths for the vector population, but omitted human births and deaths because the mean human lifespan is much longer than the duration of the outbreak. The model was as follows:$$dS_{hc}/dt = {- \beta_{h}(t){S_{hc}I_{v}}}$$$$dE_{hc}/dt = {\beta_{h}(t){S_{hc}I_{v}} - \nu_{h}E_{hc}}$$$$dI_{hc}/dt = {\nu_{h}E_{hc} - \gamma I_{hc}}$$$$dR_{hc}/dt = {\gamma I_{hc}}$$$$dS_{ha}/dt = {- \beta_{h}(t){S_{ha}I_{v}}}$$$$dE_{ha}/dt = {\beta_{h}(t){S_{ha}I_{v}} - \nu_{h}E_{ha}}$$$$dI_{ha}/dt = {\nu_{h}E_{ha} - \gamma I_{ha}}$$$$dR_{ha}/dt = {\gamma I_{ha}}$$$$dC/dt = {\nu_{h}(E_{hc} + E_{ha})}$$$$dS_{v}/dt = {\delta(t) - \beta_{v}(t)S_{v}\left( \frac{I_{hc} + I_{ha}}{N} \right) - \delta(t)S_{v}}$$$$dE_{v}/dt = {\beta_{v}(t)S_{v}\left( \frac{I_{hc} + I_{ha}}{N} \right) - \nu_{v}(t)E_{v} - \delta(t)E_{v}}$$$$dI_{v}/dt = {\nu_{v}(t)E_{v} - \delta(t)I_{v}}$$

The compartment $C$ recorded the cumulative total number of human infections, which was used for model fitting. Based on most recent Fiji census in 2007, we set the population size $N$ to be 342,000 in Central Division ([@bib21]), and split this population between the two age groups based on the populations of each reported in the census ($N_{c}$=133,020 and $N_{a}$=208,980). We estimated two initial conditions for each human age group: the initial number of infective individuals, $I_{h}^{0}$, and the initial number immune, $S_{h}^{0}$. We assumed that there were the same number of individuals initially exposed as there are individuals infectious (i.e. $E_{h}^{0} = I_{h}^{0}$). For the vector population, we only estimated the initial proportion infectious. We assumed that $E_{v}^{0} = I_{v}^{0}$ and the remaining proportion of mosquitoes were susceptible. We assumed that the mean intrinsic latent period, $1/\nu_{h}$, and human infectious period, $1/\gamma$ remained constant over time, with informative priors ([Table 7](#table7){ref-type="table"}). As detailed in the sections below, the following parameters were time dependent: transmission rate from vectors to humans, $\beta_{h}{(t)}$; transmission rate from humans to vectors, $\beta_{v}{(t)}$; mosquito lifespan, ${1/\delta}{(t)}$; and extrinsic latent period, ${1/\nu_{v}}{(t)}$. To avoid infection declining to implausibly small levels then rising again in the following season, we included potential for extinction in the model. If the number of individuals in any of the $E$ or $I$ human compartments dropped below one, the model set the value to zero. Hence if there were no exposed or infectious individuals in either of the age groups, the epidemic would end.

10.7554/eLife.34848.024

###### Parameters fitted in the model.

Prior distributions are given for all parameters, along with source if the prior incorporates a specific mean value. All rates are given in units of days$^{- 1}$.

  ---------------------------------------------------------------------------------------------------------------------------------------
  Parameter           Definition                                      Prior                                                 Source
  ------------------- ----------------------------------------------- ----------------------------------------------------- -------------
  $1/\nu_{h}$         intrinsic latent period                         Gamma($\mu$=5.9, $\sigma$=0.1)                        ([@bib14])

  $1/\gamma$          human infectious period                         Gamma($\mu$=5, $\sigma$=0.1)                          ([@bib18])

  $1/\hat{\nu_{v}}$   extrinsic latent period at 25$^{\circ}$         Gamma($\mu$=10, $\sigma$=0.1)                         ([@bib40];\
                                                                                                                            [@bib14])

  $1/\hat{\delta}$    mosquito lifespan at 25$^{\circ}$               Gamma($\mu$=8, $\sigma$=0.1)                          ([@bib57])

  $\hat{\alpha}$      biting rate at 25$^{\circ}$                     Gamma($\mu$=0.25, $\sigma$=0.1)                       ([@bib40])

  $\hat{m}$           baseline vector density                         ${\log\mathcal{U}}\left( 0,20 \right)$                [@bib3])

  $\hat{K}$           carrying capacity scaling parameter             ${\log\mathcal{U}}\left( 0,100 \right)$               

  $a_{1}$             gradient of sigmoidal change in transmission    ${\log\mathcal{U}}\left( 0,1000 \right)$              

  $a_{2}$             magnitude of sigmoidal change in transmission   ${\log\mathcal{U}}\left( 0,1 \right)$                 

  $a_{\tau}$          timing of sigmoidal change in transmission      $\log\mathcal{U}($8th March 2014, 5th April 2014$)$   ([@bib8])

  $r_{lab}$           proportion of cases reported as lab tested      ${\log\mathcal{U}}\left( 0,1 \right)$                 

  $r_{DLI}$           proportion of cases reported as DLI             ${\log\mathcal{U}}\left( 0,1 \right)$                 

  $\rho$              reporting dispersion                            ${\log\mathcal{U}}\left( 0,\infty \right)$            

  $I_{hc}^{0}$        initial number infectious aged \< 20            ${\log\mathcal{U}}\left( 0,N_{c} \right)$             

  $R_{hc}^{0}$        initial number immune aged \< 20                ${\log\mathcal{U}}\left( 0,N_{c} \right)$             

  $I_{ha}^{0}$        initial number infectious aged 20+              ${\log\mathcal{U}}\left( 0,N_{a} \right)$             

  $R_{ha}^{0}$        initial number immune aged 20+                  ${\log\mathcal{U}}\left( 0,N_{a} \right)$             

  $I_{v}^{0}$         initial proportion of infectious mosquitoes     ${\log\mathcal{U}}\left( 0,1 \right)$                 
  ---------------------------------------------------------------------------------------------------------------------------------------

Seasonal parameter variation {#s4-7}
----------------------------

We assumed that the vector-specific parameters varied over time in the model, as a result of seasonal changes in temperature and rainfall ([@bib17]). During 2013/14 in Central Division, average monthly rainfall ranged from around 100 to 400 mm, and daily temperature varied between 21 and 30$^{\circ}$C ([@bib62]; [@bib22]). Temperature reached its maximum in January/February, and minimum in August/September ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). As the daily temperature data were noisy and surveillance data were only available on a weekly timescale, in the model we defined $\text{temp}_{t}$ as the seven day moving average of temperature on day $t$ (i.e. the average temperature over the preceding week). We also defined $\text{rain}_{t}$ as the average rainfall on day $t$, interpolated from monthly data ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}).

Based on estimated mechanistic relationships between temperature and *Aedes aegypti* dynamics ([@bib35]; [@bib40]), we assumed that the following vector-specific parameters were temperature dependent: extrinsic incubation period, ${1/\nu_{v}}{(t)}$; lifespan, ${1/\delta}{(t)}$; biting rate, $\alpha{(t)}$; probability of transmission to a human, $p_{vh}{(t)}$; and probability of infection from an infectious human, $p_{hv}{(t)}$. We incorporated these temperature-dependent dynamics using symmetric ($\phi$) and asymmetric ($\psi$) unimodal thermal response functions ([@bib40]; [@bib10]):$${\phi{(x,y,T_{m},T_{0})}} = \left\{ \begin{array}{ll}
{\min{\{{y{({x - T_{0}})}{({T_{m} - x})}},1\}}} & {{\text{if}T_{0}} < x < T_{m}} \\
0 & \text{else} \\
\end{array} \right.$$$${\psi{(x,y,T_{m},T_{0})}} = \left\{ \begin{array}{ll}
{\min{\{{yx{({x - T_{0}})}\sqrt{T_{m} - x}},1\}}} & {{\text{if}T_{0}} < x < T_{m}} \\
0 & \text{else} \\
\end{array} \right.$$

The parameters were defined using the median estimated value from these functions fitted to empirical data ([@bib40]):$$1/\nu_{v}(t) = {1/(\hat{\nu_{v}}\phi(\text{temp}_{t},6.11 \times 10^{- 5},45.53,10.30)/0.10)}$$$$1/\delta(t) = {1/(\hat{\delta}\psi(\text{temp}_{t},9.02,37.66, - 0.14)/29.00)}$$$$\alpha(t) = {\hat{\alpha}\phi(\text{temp}_{t},0.00020,40.04,13.76)/0.22}$$$$p_{vh}(t) = {\phi(\text{temp}_{t},0.00083,35.78,17.23)}$$$$p_{hv}(t) = {\phi(\text{temp}_{t},0.00049,37.38,12.67)}$$

Here ${1/\nu_{v}}{(t)}$, ${1/\delta}{(t)}$ and $\alpha{(t)}$ are normalised so that they equal $1/\hat{\nu_{v}}$, $1/\hat{\delta}$, and $\hat{\alpha}$ respectively when $\text{temp}_{t} = 25^{\circ}$C. In the model, most of these parameters varied monotonically within the temperature range observed in Fiji ([Figure 5---figure supplement 1C--G](#fig5s1){ref-type="fig"}). We used informative priors for the average extrinsic latent period, $1/\hat{\nu_{v}}$, mosquito lifespan, $1/\hat{\delta_{v}}$, and biting rate, $\hat{\alpha}$ ([Table 7](#table7){ref-type="table"}).

We assumed that vector density, $m{(t)}$, could vary with both temperature and rainfall ([Figure 5---figure supplement 1H--I](#fig5s1){ref-type="fig"}). The contribution of vector density to transmission was influenced by four factors ([@bib40]): fecundity, $f$ (i.e. number of eggs produced per female mosquito per day); egg-to-adult survival probability, $e$, the mosquito development rate, $d$, and the larval carrying capacity $K$. In the model, vector density over time was equal to:$$$$where $\frac{\hat{m}}{m_{0}}$ is a scaling term and the $K/{({1 + K})}$ term incorporating carrying capacity follows from the equilibrium solution of the logistic growth model ([@bib45]) ([Figure 5---figure supplement 1I](#fig5s1){ref-type="fig"}). We assumed that $d$, $e$, and $f$ were temperature dependent, based on functions fitted to empirical data ([@bib40]), and $K$ was linearly dependent on rainfall:$$d(t) = {\phi(\text{temp}_{t},7.84e \times 10^{- 5},39.10,11.56)}$$$$e(t) = {\psi(\text{temp}_{t},13.58,38.29, - 0.0060)}$$$$f(t) = {\phi(\text{temp}_{t},0.0082,34.44,14.78)}$$$$K(t) = {\hat{K}\text{rain}_{t}/222.44}$$

$K{(t)}$ was normalised so its mean value over the year was equal to $\hat{K}$ and we set $m_{0} = 0.5752381$ so that ${m{(t)}} = {{\hat{m}K}/{({1 + K})}}$ when the temperature was 25$^{\circ}$. Prior distributions for parameter values are given in [Table 7](#table7){ref-type="table"}. In the absence of control measures, the vector-to-human, $\beta_{h}$, and human-to-vector, $\beta_{v}$, transmission rates were therefore:$$\beta_{v}(t) = {\alpha(t)p_{vh}(t)}$$$$\beta_{h}(t) = {\alpha(t)p_{hv}(t)m(t)}$$

Control measures {#s4-8}
----------------

To capture the potential additional reduction in transmission over time as a result of the national clean-up campaign between 8th and 22nd March 2014, we used a flexible sigmoid function:$$\chi(t) = \left( {1 - \frac{a_{2}}{1 + e^{- a_{1}(t - a_{\tau})}}} \right)$$

We constrained this function so that the midpoint, $a_{\tau}$, was between the start date of the campaign, 8th March 2014, and 5th April 2014, four weeks later ([Figure 5---figure supplement 1J](#fig5s1){ref-type="fig"}). We assumed that this function acted to reduce the vector-to-human transmission rate:$$\beta_{h}(t) = {\alpha(t)m(t)\chi(t)}$$

There were multiple concurrent interventions during the clean-up campaign, including promotion of awareness about protection from bites as well as larval habitat removal. Given the structure of the data available, it would not be possible to independently estimate the extent to which the campaign directly reduced vector-to-human transmission, that is $\chi{(t)}$ acting on $\alpha{(t)}$, rather than vector density, that is $\chi{(t)}$ acting on $m{(t)}$. However, if there had been a substantial effect on larval habitat capacity but not on biting rate, we may expect to infer a larger value of $a_{\tau}$, to reflect the delay in impact as a result of the time required for vector development.

Effective reproduction number {#s4-9}
-----------------------------

The next generation matrix for humans and vectors was defined as follows ([@bib38], [@bib40]):$$\begin{pmatrix}
R_{hh} & R_{hv} \\
R_{vh} & R_{vv} \\
\end{pmatrix} = \begin{pmatrix}
0 & \frac{\beta_{h}{({S_{hc} + S_{ha}})}\nu_{v}}{\delta{({\delta + \nu_{v}})}N} \\
\frac{\beta_{v}S_{v}}{\gamma} & 0 \\
\end{pmatrix}$$and the effective reproduction number, $R$, was equal to the dominant eigenvalue of this matrix. The basic reproduction, $R_{0}$, was calculated by the same method, but assuming that both humans and vectors were fully susceptible.

Model fitting {#s4-10}
-------------

The model was jointly fitted to laboratory-confirmed case data and serological data using Markov chain Monte Carlo (MCMC) via a Metropolis-Hastings algorithm. For the case data, we considered time units of one week. To construct a likelihood for the observed cases, we defined case count for week $t$ as $c_{t} = {C_{t} - C_{t - 1}}$.

Because reporting switched from lab tested to DLI during the outbreak, we jointly fitted two sets of time series data. The first dataset was lab tested cases. We defined the first observation as 4th November 2013, the week of the first confirmed case in Central Division, and the last observation as 26th May. The second dataset was DLI cases, which we fitted from 1st February until 26th May. Earlier DLI cases were not included as these were likely to reflect reporting artefacts rather than genuine infections. The two time series we fitted were disjoint: cases were either reported as lab tested or DLI.

We assumed that the two set of observed cases followed a negative binomial distributions with mean $q_{t}r_{lab}c_{t}$ and ${({1 - q_{t}})}r_{DLI}c_{t}$ respectively, and a shared dispersion parameter $\rho$, to account for potential temporal variability in reporting ([@bib9]). We used a negative binomial distribution to allow for both under- or over-reporting, the latter being potentially relevant in the final stages of the outbreak when case numbers were low. Here $q_{t}$ denotes the proportion of cases in week $t$ that are lab tested rather than reported as DLI. As it was not possible to fit this value for each week, it was fixed in the model as $q_{t} = {y_{lab}/{({{y_{lab}{(t)}} + {y_{DLI}{(t)}}})}}$, where $y_{lab}{(t)}$ and $y_{DLI}{(t)}$ are the number of observed lab tested and DLI cases in week $t$ respectively. The total expected number of reported cases in week $t$ was therefore equal to ${({{q_{t}r_{lab}} + {{({1 - q_{t}})}r_{DLI}}})}c_{t}$.

As well as fitting to surveillance data, we fitted the model to the proportion of each age group immune (as measured by seroprevalence) at the start and end of the outbreak. Let $X_{ij}$ be a binomially distributed random variable with size equal to the sample size in group $i$ and probability equal to the model predicted immunity in year $j$, and $z_{ij}$ be the observed seroprevalence in group $i$ in year $j$. The overall log-likelihood for parameter set $\theta$ given case data $Y = {\{ y_{t}\}}_{t = 1}^{T}$ and serological data $Z = {\{ z_{ij}\}}_{{i \in {\{ 1,2\}}},{j \in {\{ 2013,2015\}}}}$ was therefore:$$L{(\theta|Y,Z)} = \sum\limits_{t}\log P{(y_{t}|c_{t})} + \sum\limits_{i = 1}^{2}\sum\limits_{j \in {\{ 2013,2015\}}}\log P{(X_{ij} = z_{ij})}$$

We considered four model scenarios: an SEIR model without climate-driven variation or control, fitted to surveillance data only; SEIR model without climate-driven variation or control, fitted to surveillance and serological data; SEIR model with climate-driven variation only, fitted to surveillance and serological data; SEIR model with climate-driven variation and control, fitted to surveillance and serological data. We fitted the model to either MIA or ELISA data, to reflect two different assumptions about the relationship between seroprevalence and immunity. The model using MIA data made the assumption that only individuals who were seropositive to DENV-3 were immune to this serotype. As a sensitivity analysis, the model using ELISA data assumed that seropositivity to any DENV serotype indicated immunity to DENV-3.

All observations were given equal weight in the model fitting. The joint posterior distribution of the parameter set $\theta$ was obtained from 200,000 MCMC iterations, each with a burn-in period of 20,000 iterations. We used adaptive MCMC to improve efficiency of mixing: we iteratively adjusted the magnitude of the covariance matrix used to resample $\theta$ to obtain a target acceptance rate of 0.234 ([@bib52]). Posterior estimates for MIA and ELISA data are shown in [Supplementary files 1C--D](#supp1){ref-type="supplementary-material"}. The statistical and mathematical models were implemented in R version 3.3.1 ([@bib48]) using the deSolve package ([@bib60]) and parallelised using the doMC library ([@bib51]).

Model comparison {#s4-11}
----------------

We compared the performance of different models using the deviance information criterion (DIC), which accounts for the trade off between model fit and complexity ([@bib61]). The deviance of a model for a given parameter set, $\theta$, is given by $D(\theta) = - 2L(\theta|Y,Z)$. The DIC is therefore:$${DIC} = {{D{(\overline{\theta})}} + {\text{var}{({D{(\theta)}})}}}$$where $\overline{\theta}$ is the median of $\theta$ with respect to the posterior distribution and ${\text{var}{({D{(\theta)}})}}/2$ is the effective number of parameters. The median of $\theta$ as used rather than mean because the likelihood was non-log-concave in $\theta$, which meant that the posterior mean was a poor estimator ([@bib61]). As an additional validation, we compared models using the Akaike information criterion (AIC), which accounts for the trade off between model fit and complexity ([@bib2]). The AIC of a model for a given parameter set, $\theta$, is given by ${AIC} = {{- {2\hat{L}{(\theta)}}} + {2n_{param}}}$ where $\hat{L}{(\theta)}$ is the maximised value of the likelihood and $n_{param}$ is the number of parameters.

Data availability {#s4-12}
-----------------

Serological, surveillance and climate data are provided in [Supplementary file 3](#supp3){ref-type="supplementary-material"}. Code and data required to reproduce the main serological and modelling analysis are available at: https://github.com/adamkucharski/fiji-denv3-2014. Copy archived at https://github.com/elifesciences-publications//fiji-denv3-2014.
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Decision letter

Ferguson

Neil M

Reviewing Editor

Imperial College London

United Kingdom

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Using paired serology and surveillance data to quantify dengue transmission and control during a large outbreak in Fiji\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Prabhat Jha as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This paper presents a modelling analysis of an island epidemic of dengue-3 in 2013/4 giving insight into the effect of seasonality and control measures on transmission.

Essential revisions:

\- Greater sensitivity analysis and caveats regarding assumptions about vector population dynamics (see both reviews), including modelling larval carrying capacity or at least rainfall-driven recruitment rates.

\- On a related topic -- both reviewers comment on how seasonality was included for some parameters but not others. The main demonstrated effects of temperature are on EIP and mortality, plus rainfall via carrying capacity. There\'s not much evidence around temperature affecting biting rates/transmission coefficients. This aspect needs to be approached more systematically, given the effects of seasonality and of the clean-up campaign may be confounded.

\- More detail on the MIA data is needed -- as was done for the ELISA data, raw data should be shown (for control and DENV3 antigens), and arguably a mixture model fitted. More justification of the use of 2 assays is also needed.

\- Excluding data from the key weeks around the peak of the epidemic is problematic. Suggestions as to how this might be avoided are given in the detailed reviewer comments.

\- The Materials and methods section needs to include detail of the model comparison exercise undertaken, and tables of parameter estimates included in the Supplementary Information.

\- All datasets used need to be made public with the paper.

Reviewer \#1:

This paper presents a nicely detailed study of an island epidemic of dengue-3 in 2013/4. The most novel aspect of the study is the model-based estimation of the possible impact of a control program implemented during the epidemic. The authors make a reasonable case that there is evidence that this program had a moderate impact on transmission but to strengthen the robustness of this conclusion, aspects of the analysis require clarification and further sensitivity analysis. Detailed comments follow (but should not be viewed in light of my overall positive view):

\- The transmission model assumes a constant mosquito population size (Equation 0.10). Did the authors attempt to fit a model with density dependent regulation of larval populations, perhaps where carrying capacity is driven by rainfall: i.e. K= c + m R, where R is accumulated rainfall over some time interval T (e.g. 1 month)? This might allow a better fit to the epidemiological data -- and might eliminate any statistically significant impact of the clean-up campaign, given the sharp drop in rainfall in May and the peak in April.

\- Why assume sinusoidal variation in temperature (Equation 0.13), given the actual data is available (albeit I accept it looks reasonably sinusoidal). Then the functional form used in Mordecai et al., 2017 could be used directly, with priors on those parameters. This would seem to be more satisfying...

\- It would be better to represent the clean-up campaign (which would have reduced larval habitat, not adult mosquito density) as a (perhaps linearly increasing over time) reduction in the mosquito source term (multiplier on recruitment rate δ in Equation 0.10, or of carrying capacity) than a direct modifier of transmissibility. Doing so will offset the impact on transmission by a generation time -- i.e. \~2 weeks. It may then be possible to fit a parametrically simpler model to the exact timing of the clean-up campaign.

\- Little mention is made of the discordance of the MIA assay with the ELISA results -- how was seroconversion measured with that assay? If with just a ratio, then perhaps a mixture model would fit better? It would also be good to see the raw results for that assay -- the authors spend a lot of time modelling the ELISA results, but then use the MIA data in their default (best fit) model with no comment on the relative reliability of one vs the other. Figure 3B should also be updated to show the MIA results as well as the ELISA ones. More generally, why were two serological assays used? The motivation for this is never stated.

\- Table 2 should have the MIA results for \'Any dengue\' shown to be able to compare properly with ELISA, especially given the MIA model is the one presented in Figure 5.

\- I found it difficult to reconcile the data plotted in Figure 1A with the data points plotted on Figure 5A. Which region was being fitted to -- I presumed the whole country, but if that\'s the case, I don\'t know why the case numbers peak at about 600 in Figure 5A but at over 2000 in the black curve of Figure 1A. Are weekly case number being plotted in some places, and monthly in others? If so, I suggest using weekly numbers throughout (and updating figures to state \'weekly cases\'). It would also be good if Figure 1A was a bit bigger.

\- It was unfortunate that disease surveillance changed almost coincident with the clean-up campaign. But I was uncomfortable with the authors dropping 2-4 weeks of surveillance data from the fit. The authors refer to a sensitivity analysis for the number of weeks of data dropped, but I couldn\'t find the results. At the very least, cases of the two types for the missing 2 weeks should be plotted in Figure 5A, shown in a different colors.

\- I think the authors could avoid dropping those critical weeks of data, Assuming the transition occurred at different times for different health facilities, on week t let p~t~ denote the proportion of surveillance using lab confirmation, and (1-p~t~) be the proportion using DLI. Then the expected total number of reported cases (lab plus DLI) is \[p~t~ r~1~ + (1-p) r~2~\]c~t~. If O1~t~ and O2~t~ are the reported cases in week t from the two surveillance systems, then O1~t~/O2~t~ gives an estimate of p~t~/(1-p~t~). This chain of reasoning can be represented in the likelihood in a number of ways -- by using separate likelihoods for the lab and DLI cases, and estimating p~t~ for each of the 2 currently omitted weeks explicitly, or (more crudely) by pre-calculating p~t~ from O1~t~/O2~t~ for the transition period, and using a single likelihood for total cases (albeit still with r~1~ and r~2~ -- though a single k would need to be used in that case). Or there may be some cleverer way to do it! As an aside, I wasn\'t quite clear why different k values were fitted to the different case types -- were the estimates different?

\- Wouldn\'t a beta-binomial model (parameterised in terms of a mean p and a overdispersion parameter) be a better representation of the observation process than a negative binomial?

\- Any thoughts on why the first DLI point shown in Figure 5A is so high? Though looking at Figure 1A, perhaps this is an artefact of omitting some data points? Otherwise, could it indicate a transiently negative impact of the intervention? How does the model fit change if that point is excluded (see my early ref to the 2-4 week sensitivity analysis mentioned but not presented)?

\- Supplementary File 1 -- the EIP is a bit long in my opinion -- the blood feeding experiments of Simmons etc. might suggest 10 days is a more reasonable value. Some sensitivity analysis to this would be useful, given changing the generation time will change R~0~ and thus the relationship between infection attack rates and case incidence (perhaps!)

\- Regarding Figure S7 and the need for time-varying transmission neglects individual-level heterogeneity in exposure. I get the basic point about the limited serological attack rate, but heterogeneity could in theory explain this. Such heterogeneity is quite extreme for malaria, and likely to be comparable for dengue, given the more limited vector dispersion range. I accept that time-varying transmission is a more likely explanation, but the authors may still want to comment. In addition, while the authors didn\'t find significant predictors of seroconversion (unsurprising, given the small sample size), the RRs largely agree with intuition.

\- The model comparison exercise (Supplementary file 7) should be described in the Materials and methods section.

\- Where are all the parameter estimates for the models shown in Table S3? These need to be given. Or at least for the SEIR+climate vs SEIR+climate+control models (ELISA and MIA variants)?

\- All data needs to be released with the paper to allow reproducibility of results (i.e. raw data from serosurvey, surveillance data at the resolution used, climate data)

Reviewer \#2:

This manuscript combines a mathematical modeling analysis with two empirical data sources pertaining to the 2013-2015 epidemic of dengue in Fiji. One of the most unique aspects of this work is that the authors had the good fortune of having a number of samples collected for other purposes just prior to the epidemic that could be assayed for prior DENV exposure and used to form a longitudinal cohort that was followed up on after the epidemic in 2015. In many cases, epidemic analyses are limited to passive surveillance data, which is also examined here. Thus, this work represents one of a very limited number of opportunities to perform separate and combined analyses with these two different data types, providing insight into the relative strengths and limitations of the two and providing information about the extent of discrepancy between inferences made on one, the other, or both. Moreover, a number of different forms of analysis were conducted, including a mathematical transmission model that was fitted to both data types.

Overall, I view this manuscript as having many strengths and believe that it reflects a nice combination of unique data and thoughtful analysis. My primary criticisms of the paper have to do with where emphasis is placed in terms of results, writing, and take-home messages. My impression from reading this manuscript is that some of the primary results in the authors\' view pertain to what factors drove the epidemic and their conclusion that vector control made a perceptible contribution to ending the epidemic. While I concede that these claims are plausible and perhaps even likely, I had reservations about the extent of inference drawn based on the analyses that were performed. The transmission model used here is a standard choice, but the reality is that models of this form were devised for theoretical purposes rather than inferential ones. That is not to say that models of this form cannot be used for inference -- indeed, I am engaged in work of that nature myself -- but there is a great deal of uncertainty in many structural aspects of these models that must be acknowledged and examined before reliable inferences can be drawn. My concern is that the authors have not done enough in that respect.

To elaborate, in the Abstract, it is stated that \"Mathematical modelling showed that temperature-driven variation in transmission and herd immunity could not fully explain observed dynamics.\" The authors then go on to state that there was an additional reduction in transmission explained by a vector clean-up campaign. While they may be right, a problem with these statements here and elsewhere in the manuscript is that the one relatively simple model chosen was used to make a rather conclusive statement about what did or did not drive the observed dynamics (e.g., \"mathematical modeling\" rather than \"a mathematical model\" showed). I can think of numerous ways in which this model could be elaborated on or alternatives proposed (and not necessarily more mechanistic detail but potentially more flexibility from more statistical descriptions in certain places) that would likely better fit the data and could lead to different conclusions. For example, the model did not allow for a dynamic vector population, which could be a major factor in driving seasonal transmission in its own right but also leads to changes in the demographic composition of the vector population that are extremely important epidemiologically and that interact in important ways with control measures. And while there was some allowance for seasonality, it entered the model in a somewhat odd way (effectively influencing biting rate and vector competence but not EIP, mortality, etc.). Given how quickly a list of potentially major concerns about the model\'s structure can be generated (not to mention the very particular assumption of sinusoidal seasonality, which there is no good reason in principle to expect as opposed to other seasonal forms), it may be overreaching to make strong claims about ruling out or supporting certain factors in driving the epidemic. The results related directly to the model are suggestive, but that\'s about it.

Inferences based on the serological data are also not completely straightforward. First, there is the difference between what the IgG and MIA assays tell you about: infection with one\'s first serotype and infection with a particular serotype. Second, the model does not account for multiple serotypes and is thus presumably intended as a DENV-3 model only. The surveillance data are reflective of all DENV serotypes, however, so some discrepancy between models fitted to these data sources is to be expected based on that alone. Whether in fitting the model or performing the age analysis, a lot of care must be taken when dealing with data that speak to non-specific seroconversion. The reason is that there could have been people experiencing their second infection but who did not seroconvert because they were already seroconverted by the time of the period of observation. The MIA data address this issue to a large extent, but that seems to be done in an either/or way using IgG or MIA but not both sources of information. Additionally, I do not have much familiarity with MIA and would have appreciated more exposition about its validity. For example, how do its abilities to infer serotype-specific exposure compare to PRNT? Could some PRNTs be done on samples from this study to demonstrate that? Are results interpretable for individuals with multiple DENV exposures?

10.7554/eLife.34848.030

Author response

> Essential revisions:
>
> \- Greater sensitivity analysis and caveats regarding assumptions about vector population dynamics (see both reviews), including modelling larval carrying capacity or at least rainfall-driven recruitment rates.

We have updated the manuscript to include rainfall dependency in mosquito density (see response 1.1) as well as discussion of recruitment rates and control measures (see response 1.3).

> \- On a related topic -- both reviewers comment on how seasonality was included for some parameters but not others. The main demonstrated effects of temperature are on EIP and mortality, plus rainfall via carrying capacity. There\'s not much evidence around temperature affecting biting rates/transmission coefficients. This aspect needs to be approached more systematically, given the effects of seasonality and of the clean-up campaign may be confounded.

We have updated the model to systematically include temperature-driven variation on all relevant vector parameters. The potential confounding of clean-up campaign and seasonality is also discussed in more detail. These changes are detailed in responses 1.1-- 1.3 and 2.3--2.4.

> \- More detail on the MIA data is needed -- as was done for the ELISA data, raw data should be shown (for control and DENV3 antigens), and arguably a mixture model fitted. More justification of the use of 2 assays is also needed.

The updated manuscript includes more detail about the MIA data and how it relates to the ELISA results, as well as additional neutralisation assay results for validation (see responses 1.4 and 2.5 below).

> \- Excluding data from the key weeks around the peak of the epidemic is problematic. Suggestions as to how this might be avoided are given in the detailed reviewer comments.

We have updated the fitting procedure to include both time series during these key weeks (see responses 1.7--1.8 below).

> \- The Materials and methods section needs to include detail of the model comparison exercise undertaken, and tables of parameter estimates included in the Supplementary Information.

These have now been added to the manuscript, in subsection "Model comparison" and supplementary files showing parameter estimates.

> \- All datasets used need to be made public with the paper.

We realise we could have been clearer about data availability. The data and code required to reproduce the analysis are already available on GitHub (http://github.com/adamkucharski/fiji-denv3-2014), as noted in the submitted manuscript and transparent reporting form. In the revised manuscript, we have also included a supplementary file with all the relevant data in one place.

> Reviewer \#1:
>
> This paper presents a nicely detailed study of an island epidemic of dengue-3 in 2013/4. The most novel aspect of the study is the model-based estimation of the possible impact of a control program implemented during the epidemic. The authors make a reasonable case that there is evidence that this program had a moderate impact on transmission but to strengthen the robustness of this conclusion, aspects of the analysis require clarification and further sensitivity analysis. Detailed comments follow (but should not be viewed in light of my overall positive view):
>
> \- The transmission model assumes a constant mosquito population size (Equation 0.10). Did the authors attempt to fit a model with density dependent regulation of larval populations, perhaps where carrying capacity is driven by rainfall: i.e. K=c + m R, where R is accumulated rainfall over some time interval T (e.g. 1 month)? This might allow a better fit to the epidemiological data -- and might eliminate any statistically significant impact of the clean-up campaign, given the sharp drop in rainfall in May and the peak in April.

1.1 We did not fit a rainfall-dependent model initially as we noted that the peak in rainfall (April) occurred after the outbreak peak (Feb/Mar), and so it was unlikely that the main decline in transmission was the result of a reduction in carrying capacity. However, we realise that it would be helpful to test this quantitatively and now include a simple function to allow mosquito density to depend on observed rainfall via a carrying capacity term. This is described in subsection"Seasonal parameter variation". The updated results match intuition, with the additional rainfall term in our model unable to improve model fit, and hence the model with both climate and control still performs better than the climate-only model.

> \- Why assume sinusoidal variation in temperature (Equation 0.13), given the actual data is available (albeit I accept it looks reasonably sinusoidal). Then the functional form used in Mordecai et al., 2017could be used directly, with priors on those parameters. This would seem to be more satisfying.

1.2 We initially used a sinusoidal function to approximate seasonal variation because this captured much of the observed change in temperature. However, we realise that it would be more rigorous to implement temperature-dependency directly -- in the updated manuscript, the vector-specific parameters vary over time based on observed temperature. This approach is described in subsection "Seasonal parameter variation", and led to the same overall conclusions about which model performed best.

> \- It would be better to represent the clean-up campaign (which would have reduced larval habitat, not adult mosquito density) as a (perhaps linearly increasing over time) reduction in the mosquito source term (multiplier on recruitment rate δ in Equation 0.10, or of carrying capacity) than a direct modifier of transmissibility. Doing so will offset the impact on transmission by a generation time -- i.e. \~2 weeks. It may then be possible to fit a parametrically simpler model to the exact timing of the clean-up campaign.

1.3 There were multiple interventions during the clean-up campaign, including

promotion of awareness about prevention and protection, as well as larval habitat removal. Unfortunately, it is not possible to disentangle these effects with the data available. We therefore included a single term that acts on the vector-to-human transmission rate and could therefore capture both/either of these interventions. We clarify this in subsection "control measures":

"There were multiple concurrent interventions during the clean-up campaign, including promotion of awareness about protection from bites as well as larval habitat removal. Given the structure of the data available, it would not be possible to independently estimate the extent to which the campaign directly reduced vector-tohuman transmission (i.e. κ(t) acting on α(t)) rather than vector density (i.e. κ(t) acting on m(t)). However, if there was a substantial effect on larval habitat capacity but not on biting rate, we may expect to infer a larger value of a~τ~, to reflect the delay in impact as a result of the time required for vector development."

We also acknowledge the limitation in the Discussion section:

"We used a flexible time-dependent transmission rate to capture a potential reduction in transmission as a result of control measures in March 2014. The clean-up campaign included multiple concurrent interventions, which occurred alongside ongoing media coverage of the outbreak; it was therefore not possible to untangle how specific actions -- such as vector habitat removal or changes in community behaviour that reduced chances of being bitten -- contributed to the outbreak decline"

> \- Little mention is made of the discordance of the MIA assay with the ELISA results -- how was seroconversion measured with that assay? If with just a ratio, then perhaps a mixture model would fit better? It would also be good to see the raw results for that assay -- the authors spend a lot of time modelling the ELISA results, but then use the MIA data in their default (best fit) model with no comment on the relative reliability of one vs the other. Figure 3B should also be updated to show the MIA results as well as the ELISA ones. More generally, why were two serological assays used? The motivation for this is never stated.

1.4 We have updated the Materials and methods section to clarify the reasons for using different assays:

"Because the indirect IgG ELISA does not distinguish between DENV serotypes, samples were also tested against each of the four specific DENV serotypes using a recombinant antigen-based microsphere immunoassay (MIA), as previously used to examine seroprevalence against different flaviviruses in French Polynesia \[20, 30\]. Specifically, we wanted to measure the change in seropositivity to DENV-3 during the study period. As an additional validation, a subset of fifty samples from Central Division -- including a mixture of those seronegative and seropositive by ELISA and MIA -- were tested for the presence of neutralising antibodies against each of the four DENV serotypes using a neutralisation assay as previously described \[31\]. A neutralisation titre of ≥20 was defined as seropositive (Figure 6---figure supplement 2A)."

We also provide more details about how the different assays compare with one another:

"For both MIA and neutralisation assay results, the largest change in seropositivity was for DENV-3 (Supplementary File 1B). When seropositivity to any DENV (i.e. seropositive to at least one serotype) was compared, a similar change was observed across ELISA, MIA and neutralisation assay results between 2013 and 2015."

Finally, we show the raw distribution of MIA values, and explain that the distribution of these values means that is not possible to fit a mixture model to such data:

"It was not possible to perform the same analysis using the MIA data because unlike the ELISA and neutralisation assay data, the raw MIA values did not follow a bimodal distribution that indicated likely naive and previously exposed individuals (Figure 6---figure supplement 2B)"

> \- Table 2 should have the MIA results for \'Any dengue\' shown to be able to compare properly with ELISA, esp given the MIA model is the one presented in Figure 5.

1.5 We have now added these results to the table.

> \- I found it difficult to reconcile the data plotted in Figure 1A with the data points plotted on Figure 5A. Which region was being fitted to -- I presumed the whole country, but if that\'s the case, I don\'t know why the case numbers peak at about 600 in Figure 5A but at over 2000 in the black curve of Figure 1A. Are weekly case number being plotted in some places, and monthly in others? If so, I suggest using weekly numbers throughout (and updating figures to state \'weekly cases\'). It would also be good if Figure 1A was a bit bigger.

1.6 The model in Figure 5 was fitted to Central Division only, with lab tested cases shown. The data shown in Figure 1A was all reported cases (i.e. DLI and lab), which is why the totals were larger. We realise these could have been labelled more clearly: the updated Figure 1A now shows lab tested cases, with a larger figure, to match the data shown in Figure 6. We have also relabelled Figure 5 to clarify what region is fitted.

> \- It was unfortunate that disease surveillance changed almost coincident with the clean-up campaign. But I was uncomfortable with the authors dropping 2-4 weeks of surveillance data from the fit. The authors refer to a sensitivity analysis for the number of weeks of data dropped, but I couldn\'t find the results. At the very least, cases of the two types for the missing 2 weeks should be plotted in Figure 5A, shown in a different colors.

1.7 We agree that the change in surveillance during the outbreak poses a challenge for inference. In Supplementary file 3 of the original submitted manuscript we showed a sensitivity analysis for different weeks of data omitted, finding that the number of weeks omitted (between 2--4) did not change our overall conclusion. However, we appreciated the reviewer's suggestion below of including these additional weeks of data in the fitting, and now do this -- details are given in response 1.8 below. We also now show both time series in Figure 5 and the corresponding supplementary figures.

> \- I think the authors could avoid dropping those critical weeks of data, Assuming the transition occurred at different times for different health facilities, on week t let p~t~ denotes the proportion of surveillance using lab confirmation, and (1-p~t~) be the proportion using DLI. Then the expected total number of reported cases (lab plus DLI) is \[p~t~ r~1~ + (1-p) r~2~\]c~t~. If O1t and O2~t~ are the reported cases in week t from the two surveillance systems, then O1~t~/O2~t~ gives an estimate of p~t~ /(1-p~t~). This chain of reasoning can be represented in the likelihood in a number of ways -- by using separate likelihoods for the lab and DLI case, and estimating p~t~ for each of the 2 currently omitted weeks explicitly, or (more crudely) by pre-calculating p~t~ from O1~t~ /O2~t~ for the transition period, and using a single likelihood for total cases (albeit still with r~1~ and r~2~ -- though a single k would need to be used in that case). Or there may be some cleverer way to do it! As an aside, I wasn\'t quite clear why different k values were fitted to the different case types -- were the estimates different?

1.8 Thank you for this suggestion. We have now updated the model to jointly fit to both datasets over the course of the outbreak. Rather than try and calculate the ratio for all weeks, which would not be identifiable, we used the reviewer's suggestion of pre-calculating p~t~. This is detailed in subsection "Model Fitting".

The original k values were fitted independently to account for potential differences in reporting variability by type, but in the updated framework, we use the same k so that the cases can be fit jointly, as described above.

> \- Wouldn\'t a beta-binomial model (parameterised in terms of a mean p and a overdispersion parameter) be a better representation of the observation process than a negative binomial?

1.9 We used a negative binomial rather than a beta-binomial as it interprets reporting as a rate rather than as a proportion, and hence allows for the weekly variability to potentially generate over-reporting. This is a particularly useful property in the later stages of the outbreak, where case numbers are low. We now mention this in the updated Materials and methods section.

"We used a negative binomial distribution to allow for both under- or over-reporting, the latter being potentially relevant in the final stages of the outbreak when case numbers were low."

> \- Any thoughts on why the first DLI point shown in Figure 5A is so high? Though looking at Figure 1A, perhaps this is an artefact of omitting some data points? Otherwise, could it indicate a transiently negative impact of the intervention? How does the model fit change if that point is excluded (see my early ref to the 2-4 week sensitivity analysis mentioned but not presented)?

1.10 This was indeed an artefact of omitting prior data points, but this is no longer an issue in the figure as the updated plot shows both time series.

*- Supplementary File 1 -- the EIP is a bit long in my opinion -- the blood feeding experiments of Simmons etc. might suggest 10 days is a more reasonable value. Some sensitivity analysis to this would be useful, given changing the generation time will change* R~0~*and thus the relationship between infection attack rates and case incidence (perhaps!)*

1.11 In the updated model, we include temperature dependent EIP based on experimental data including that of Simmons et al., as detailed in response 1.2 above. The expected EIP in our new prior distribution, based on these data, is 10 days when the temperature is 25°C. However, we include some uncertainty in this prior (Figure 5---figure supplement 4), and so if the mean EIP is slightly longer or shorter in reality, this uncertainty will be reflected in the model results.

> \- Regarding Figure S7 and the need for time-varying transmission neglects individual-level heterogeneity in exposure. I get the basic point about the limited serological attack rate, but heterogeneity could in theory explain this. Such heterogeneity is quite extreme for malaria, and likely to be comparable for dengue, given the more limited vector dispersion range. I accept that time-varying transmission is a more likely explanation, but the authors may still want to comment. In addition, while the authors didn\'t find significant predictors of seroconversion (unsurprising, given the small sample size), the RRs largely agree with intuition.

1.12 We agree that this point would be worth acknowledging, and now address in the Discussion section:

"Some of the discrepancy between the high attack rate predicted by a randomly mixing model and lower observed seroconversion could in theory be explained by heterogeneity in transmission \[18\], but the high level of seroprevalence in older age groups suggests that only a small proportion of individuals have consistently avoided infection (Figure 3)."

We also now comment on the risk factors in the Discussion section:

"We did not identify environmental factors that were significantly associated with infection, likely as a result of the relatively small sample size in the serological survey, but the estimated odds ratios were broadly consistent with factors that would be expected to increase or decrease infection risk (Table 3)."

> \- The model comparison exercise (Supplementary file 7) should be described in the Materials and methods section.

1.13 We have added details of the model comparison to the Materials and methods section.

> \- Where are all the parameter estimates for the models shown in Table S3? These need to be given. Or at least for the SEIR+climate vs SEIR+climate+control models (ELISA and MIA variants)?

1.14 We have updated the Supplementary Information to include Tables showing parameter estimates for the three models and two serological data types. Full model outputs can also be reproduced using the accompanying code (see response 1.15).

> \- All data needs to be released with the paper to allow reproducibility of results (i.e. raw data from serosurvey, surveillance data at the resolution used, climate data)

1.15 The data and code required to reproduce the analysis are already available on GitHub (http://github.com/adamkucharski/fiji-denv3-2014), as was noted in the Materials and methods section and on the transparent reporting form. However, we realise we could have been clearer about data availability in the submission information and have made this update.

> Reviewer \#2:
>
> This manuscript combines a mathematical modeling analysis with two empirical data sources pertaining to the 2013-2015 epidemic of dengue in Fiji. One of the most unique aspects of this work is that the authors had the good fortune of having a number of samples collected for other purposes just prior to the epidemic that could be assayed for prior DENV exposure and used to form a longitudinal cohort that was followed up on after the epidemic in 2015. In many cases, epidemic analyses are limited to passive surveillance data, which is also examined here. Thus, this work represents one of a very limited number of opportunities to perform separate and combined analyses with these two different data types, providing insight into the relative strengths and limitations of the two and providing information about the extent of discrepancy between inferences made on one, the other, or both. Moreover, a number of different forms of analysis were conducted, including a mathematical transmission model that was fitted to both data types.
>
> Overall, I view this manuscript as having many strengths and believe that it reflects a nice combination of unique data and thoughtful analysis. My primary criticisms of the paper have to do with where emphasis is placed in terms of results, writing, and take-home messages. My impression from reading this manuscript is that some of the primary results in the authors\' view pertain to what factors drove the epidemic and their conclusion that vector control made a perceptible contribution to ending the epidemic. While I concede that these claims are plausible and perhaps even likely, I had reservations about the extent of inference drawn based on the analyses that were performed. The transmission model used here is a standard choice, but the reality is that models of this form were devised for theoretical purposes rather than inferential ones. That is not to say that models of this form cannot be used for inference -- indeed, I am engaged in work of that nature myself -- but there is a great deal of uncertainty in many structural aspects of these models that must be acknowledged and examined before reliable inferences can be drawn. My concern is that the authors have not done enough in that respect.

2.1 We agree that while mathematical models can provide suggestions about potential factors driving the epidemic, such models do have limitations. In our analysis, we tried to be thorough in evaluating potential alternative explanations for observed dynamics. For example, we used DLI data as well as lab tested data, to avoid attributing a decline to control rather than a change in reporting, and jointly fitted to both serology and surveillance data to better examine the role of herd immunity. However, we realise that we could have done more to acknowledge the uncertainty involved and include more plausible assumptions. We have now made such changes, as detailed in responses 2.2--2.8 below.

> To elaborate, in the Abstract, it is stated that \"Mathematical modelling showed that temperature-driven variation in transmission and herd immunity could not fully explain observed dynamics.\" The authors then go on to state that there was an additional reduction in transmission explained by a vector clean-up campaign. While they may be right, a problem with these statements here and elsewhere in the manuscript is that the one relatively simple model chosen was used to make a rather conclusive statement about what did or did not drive the observed dynamics (e.g., \"mathematical modeling\" rather than \"a mathematical model\" showed).

2.2 We have updated the manuscript to make it clearer that we were fitting with one specific type of model, and that the results presented come from this model. For example, in the Abstract we now state:

"A mathematical model jointly fitted to surveillance and serological data suggested that climate-driven variation in transmission and herd immunity could not fully explain observed dynamics. However, the model showed evidence of an additional reduction in transmission coinciding with a vector clean-up campaign, which may have contributed to the decline in cases in the later stages of the outbreak."

And in the Discussion section:

"With the addition of serological data in the model fitting, however, our model was able to quantify the relative contribution of herd immunity, climate and control measures to the outbreak dynamics. In particular, this model suggested that seasonal variation and herd immunity alone could fully explain the fall in transmission."

> I can think of numerous ways in which this model could be elaborated on or alternatives proposed (and not necessarily more mechanistic detail but potentially more flexibility from more statistical descriptions in certain places) that would likely better fit the data and could lead to different conclusions. For example, the model did not allow for a dynamic vector population, which could be a major factor in driving seasonal transmission in its own right but also leads to changes in the demographic composition of the vector population that are extremely important epidemiologically and that interact in important ways with control measures. And while there was some allowance for seasonality, it entered the model in a somewhat odd way (effectively influencing biting rate and vector competence but not EIP, mortality, etc.).

2.3 As the implementation of seasonality and vector dynamics was also raised by reviewer 1, we have expanded the model to include temperature and rainfall dependent vector parameters. These additions are described in subsection "Seasonal parameter variation".

> Given how quickly a list of potentially major concerns about the model\'s structure can be generated (not to mention the very particular assumption of sinusoidal seasonality, which there is no good reason in principle to expect as opposed to other seasonal forms), it may be overreaching to make strong claims about ruling out or supporting certain factors in driving the epidemic. The results related directly to the model are suggestive, but that\'s about it.

2.4 We have made substantial amendments to model structure and assumptions, including removing the assumptions of sinusoidal seasonality (see response 1.2 above) and adding rainfall and temperature dependent parameters (response 2.3). We have also edited wording to make it clearer that results are dependent on our model (response 2.2). Although there are several limitations our approach, as acknowledged in the Discussion section, we believe the model results still provide useful insights into the outbreak dynamics and illustrate how combining surveillance and serological data can suggest results that would not be obtained with surveillance data alone.

> Inferences based on the serological data are also not completely straightforward. First, there is the difference between what the IgG and MIA assays tell you about: infection with one\'s first serotype and infection with a particular serotype. Second, the model does not account for multiple serotypes and is thus presumably intended as a DENV-3 model only. The surveillance data are reflective of all DENV serotypes, however, so some discrepancy between models fitted to these data sources is to be expected based on that alone. Whether in fitting the model or performing the age analysis, a lot of care must be taken when dealing with data that speak to non-specific seroconversion. The reason is that there could have been people experiencing their second infection but who did not seroconvert because they were already seroconverted by the time of the period of observation. The MIA data address this issue to a large extent, but that seems to be done in an either/or way using IgG or MIA but not both sources of information.

2.5 We agree that it is challenging to interpret ELISA results given potential prior exposure. In our analysis, we therefore used two different approaches to account for this issue.

First, we examined the change in raw ELISA values, rather than just relying on seropositivity. This made it possible to identify individuals who were initially seropositive, but subsequently had evidence of infection. We clarify this in subsection "'Serological modelling"':

"Based on seropositivity in 2015 alone, it would not be possible to identify infections during the 2013/14 outbreak among individuals who were initially ELISA seropositive in 2013. We therefore examined the changes in paired individual-level ELISA values between 2013 and 2015."

We further address the issue of non-specific seroconversion in the Discussion section:

"In addition, if age-specific infection rates are indeed higher in younger groups, it means that estimating population attack rates based on the proportion of seronegative individuals infected may over-estimate the true extent of infection. Focusing on the seronegative subset of the population leads to children being oversampled, which in our data inflates attack rate estimates by around 10% compared to estimates based on change in ELISA value"

Second, we compared model results generated under the assumption that non-specific seropositivity conferred immunity (i.e. using ELISA data) with the assumption that only DENV-3 seropositivity reflected immunity (i.e. using MIA data). Our overall conclusions about the role of climate and control measures were the same (Table 5), indicating that our analysis was not strongly dependent on the assumption used.

These assumptions are now clarified in the Materials and methods section:

"We also fitted the model to either MIA or ELISA seroprevalence data, to reflect two different assumptions about the relationship between seroprevalence immunity. The model using MIA data assumed that only individuals who were seropositive to DENV-3 were immune; the model using ELISA data assumed that seropositivity to any DENV serotype conferred immunity."

> Additionally, I do not have much familiarity with MIA and would have appreciated more exposition about its validity. For example, how do its abilities to infer serotype-specific exposure compare to PRNT? Could some PRNTs be done on samples from this study to demonstrate that? Are results interpretable for individuals with multiple DENV exposurs?

2.6 We now include a comparison with results from neutralisation assay performed on a subset of 50 samples. The results of this validation are described in the updated Materials and methods section:

"For both MIA and neutralisation assay results, the largest change in seropositivity was for DENV-3 (Supplementary file 1B). When seropositivity to any DENV (i.e. seropositive to at least one serotype) was compared, a similar change was observed across ELISA, MIA and neutralisation assay results between 2013 and 2015."
